121 related articles for article (PubMed ID: 21913182)
1. Multicenter study identified molecular blood-born protein signatures for Wilms Tumor.
Schmitt J; Heisel S; Keller A; Leidinger P; Ludwig N; Habel N; Furtwängler R; Nourkami-Tutdibi N; Wegert J; Grundy P; Gessler M; Graf N; Lenhof HP; Meese E
Int J Cancer; 2012 Aug; 131(3):673-82. PubMed ID: 21913182
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody signature differentiates Wilms tumor patients from neuroblastoma patients.
Schmitt J; Keller A; Nourkami-Tutdibi N; Heisel S; Habel N; Leidinger P; Ludwig N; Gessler M; Graf N; Berthold F; Lenhof HP; Meese E
PLoS One; 2011; 6(12):e28951. PubMed ID: 22194956
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic accuracy and clinical utility of pediatric renal tumor biopsy: Report of the UK experience in the SIOP UK WT 2001 trial.
Jackson TJ; Williams RD; Brok J; Chowdhury T; Ronghe M; Powis M; Pritchard-Jones K; Vujanić GM;
Pediatr Blood Cancer; 2019 Jun; 66(6):e27627. PubMed ID: 30761727
[TBL] [Abstract][Full Text] [Related]
4. Wilms' tumor--single-center experience with renal surgery.
Seseke F; Zöller G; Ringert RH
Scand J Urol Nephrol; 2004; 38(5):373-7. PubMed ID: 15764247
[TBL] [Abstract][Full Text] [Related]
5. The role of preoperative chemotherapy in the treatment of nephroblastoma: the SIOP experience. Societe Internationale d'Oncologie Pediatrique.
Godzinski J; Tournade MF; De Kraker J; Ludwig R; Weirich A; Voute PA; Burgers JM; Habrand JL; Sandstedt B; Ducourtieux M
Semin Urol Oncol; 1999 Feb; 17(1):28-32. PubMed ID: 10073403
[TBL] [Abstract][Full Text] [Related]
6. [Nephrogenic tumors].
Wiesbauer P
Radiologe; 2008 Oct; 48(10):932-9. PubMed ID: 18854965
[TBL] [Abstract][Full Text] [Related]
7. Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades.
Dyachenko L; Havrysh K; Lytovchenko A; Dosenko I; Antoniuk S; Filonenko V; Kiyamova R
Dis Markers; 2016; 2016():5128720. PubMed ID: 27847402
[No Abstract] [Full Text] [Related]
8. Response to letter commenting on "Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)".
; van den Heuvel-Eibrink MM; Pritchard-Jones K; van Tinteren H; Graf N
Eur J Cancer; 2015 May; 51(8):995-6. PubMed ID: 25840668
[No Abstract] [Full Text] [Related]
9. Does preoperative chemotherapy ease the surgical procedure for Wilms tumor?
Bogaert GA; Heremans B; Renard M; Bruninx L; De Wever L; Van Poppel H
J Urol; 2009 Oct; 182(4 Suppl):1869-74. PubMed ID: 19692015
[TBL] [Abstract][Full Text] [Related]
10. Anti-neuronal antibodies in patients with cancer.
Posner JB
Ann Neurol; 2004 Nov; 56(5):609-10. PubMed ID: 15505822
[No Abstract] [Full Text] [Related]
11. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.
Takahashi M; Yang XJ; Lavery TT; Furge KA; Williams BO; Tretiakova M; Montag A; Vogelzang NJ; Re GG; Garvin AJ; Söderhäll S; Kagawa S; Hazel-Martin D; Nordenskjold A; Teh BT
Cancer Res; 2002 Nov; 62(22):6598-605. PubMed ID: 12438255
[TBL] [Abstract][Full Text] [Related]
12. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic potential of zinc finger protein-specific autoantibodies and associated linear B-cell epitopes in colorectal cancer.
O'Reilly JA; Fitzgerald J; Fitzgerald S; Kenny D; Kay EW; O'Kennedy R; Kijanka GS
PLoS One; 2015; 10(4):e0123469. PubMed ID: 25875936
[TBL] [Abstract][Full Text] [Related]
14. A 23-year experience with malignant renal tumors in infancy and childhood.
Tröbs RB; Hänsel M; Friedrich T; Bennek J
Eur J Pediatr Surg; 2001 Apr; 11(2):92-8. PubMed ID: 11371043
[TBL] [Abstract][Full Text] [Related]
15. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
Roberts DJ; Haber D; Sklar J; Crum CP
Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma.
Chen G; Wang X; Yu J; Varambally S; Yu J; Thomas DG; Lin MY; Vishnu P; Wang Z; Wang R; Fielhauer J; Ghosh D; Giordano TJ; Giacherio D; Chang AC; Orringer MB; El-Hefnawy T; Bigbee WL; Beer DG; Chinnaiyan AM
Cancer Res; 2007 Apr; 67(7):3461-7. PubMed ID: 17409457
[TBL] [Abstract][Full Text] [Related]
17. [Human esophageal carcinoma antigens screened by serologic analysis of recombinant cDNA expression libraries (SEREX)].
Yu L; Hu H; Ran YL; Peng LP; Li JW; Yang ZH
Ai Zheng; 2007 Jan; 26(1):100-5. PubMed ID: 17222377
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic treatment of renal cancer in children: a multicentric study and review of oncologic and surgical complications.
Varlet F; Petit T; Leclair MD; Lardy H; Geiss S; Becmeur F; Ravasse P; Rod J; de Lambert G; Braik K; Lardellier-Reynaud F; Lopez M
J Pediatr Urol; 2014 Jun; 10(3):500-5. PubMed ID: 24332932
[TBL] [Abstract][Full Text] [Related]
19. Immune expression in children with Wilms tumor: a pilot study.
Holl EK; Routh JC; Johnston AW; Frazier V; Rice HE; Tracy ET; Nair SK
J Pediatr Urol; 2019 Oct; 15(5):441.e1-441.e8. PubMed ID: 30981637
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
